The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Mechanism of oligonucleotide release from cationic liposomes.
Open accessAbstract
We propose a mechanism for oligonucleotide (ODN) release from cationic lipid complexes in cells that accounts for various observations on cationic lipid-nucleic acid-cell interactions. Fluorescent confocal microscopy of cells treated with rhodamine-labeled cationic liposome/ fluorescein-labeled ODN (F-ODN) complexes show the F-ODN separates from the lipid after internalization and enters the nucleus leaving the fluorescent lipid in cytoplasmic structures. ODN displacement from the complex was studied by fluorescent resonance energy transfer. Anionic liposome compositions (e.g., phosphatidylserine) that mimic the cytoplasmic facing monolayer of the cell membrane released ODN from the complex at about a 1:1 (-/+) charge ratio. Release was independent of ionic strength and pH. Physical separation of the F-ODN from monovalent and multivalent cationic lipids was confirmed by gel electrophoresis. Fluid but not solid phase anionic liposomes are required, whereas the physical state of the cationic lipids does not effect the release. Water soluble molecules with a high negative linear charge density, dextran sulfate, or heparin also release ODN. However, ATP, spermidine, spermine, tRNA, DNA, polyglutamic acid, polylysine, bovine serum albumin, or histone did not release ODN, even at 100-fold charge excess (-/+). Based upon these results, we propose that the complex, after internalization by endocytosis, induces flip-flop of anionic lipids from the cytoplasmic facing monolayer. Anionic lipids laterally diffuse into the complex and form a charged neutralized ion-pair with the cationic lipids. This leads to displacement of the ODN from the cationic lipid and its release into the cytoplasm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid
Zabner, J., Fasbender, A., Moninger, T., Poellinger, K. A., & Welsh, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18997 · Cited by 1,412
Cationic liposome-mediated transfection
Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J., DEMENEIX, B. A., Loeffler, J.-P., & Pérez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Bennett, C. F., Chiang, M. Y., Chan, H. E. H., Shoemaker, J. E., & Mirabelli, C. K. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09229-6 · Cited by 612
Zhou, X., & Huang, L. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90066-3 · Cited by 501
Chiang, M. Y.-N., Chan, H., Zounes, M. A., Freier, S., Lima, W. F., & Bennett, C. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55250-9 · Cited by 463
Structure and Biological Activity of Heparin
Casu, B. (1985) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(08)60067-0 · Cited by 429
A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.
Rose, J. K., Buonocore, L., & Whitt, M. A. (1991) · PubMed · Cited by 385
Cited by
Sorted by citations
Items 101–200 of 634
Catalytic Nucleic Acids: From Lab to Applications
Sun, L., Cairns, M. J., Saravolac, E. G., Baker, A., & Gerlach, W. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01455-8 · Cited by 121
Endosomal Escape Pathways for Non-Viral Nucleic Acid Delivery Systems
Liang, W., & Lam, J. K. W. (2012) · InTech eBooks · doi:10.5772/46006 · Cited by 137
Gene Chemistry: Functionally and Conformationally Intact Fluorescent Plasmid DNA
Zelphati, O., Liang, X., Hobart, P. M., & Felgner, P. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950019156 · Cited by 122
Self-citationQuantitative Analysis of Synthetic Gene Delivery Vector Design Properties
Varga, C. M., Hong, K., & Lauffenburger, D. A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0475 · Cited by 120
Engineering Nanocarriers for siRNA Delivery
Tan, S. J., Kiatwuthinon, P., Roh, Y. H., Kahn, J. S., & Luo, D. (2011) · Small · doi:10.1002/smll.201001389 · Cited by 119
Cellular delivery of antisense oligonucleotides
Lebedeva, I. V. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00088-6 · Cited by 118
DEMENEIX, B. A., & Behr, J. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)53008-6 · Cited by 116
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines
Goswami, R., Chatzikleanthous, D., Lou, G., Giusti, F., Bonci, A., Taccone, M., Brazzoli, M., Gallorini, S., Ferlenghi, I., Berti, F., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00084 · Cited by 113
Zhao, T., Zhang, H., Guo, Y., Zhang, Q., Hua, G., Lu, H., Hou, Q., Liu, H., & Fan, Z. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402040 · Cited by 113
Hinrichs, W. L. J., Manceñido, F. A., Sanders, N. N., Braeckmans, K., Smedt, S. C. D., Demeester, J., & Frijlink, H. W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.032 · Cited by 117
Non-viral nanosystems for systemic siRNA delivery
David, S., Pitard, B., Benoît, J., & Passirani, C. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.013 · Cited by 115
Selective tissue targeting of synthetic nucleic acid drugs
Seth, P. P., Tanowitz, M., & Bennett, C. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125228 · Cited by 112
How Do Biomolecules Cross the Cell Membrane?
Pei, D. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00560 · Cited by 106
Nonviral gene delivery: techniques and implications for molecular medicine
Parker, A. L., Newman, C. M., Briggs, S. S., Seymour, L. W., & Sheridan, P. J. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403006562 · Cited by 109
Sato, N., Kobayashi, H., Saga, T., Nakamoto, Y., Ishimori, T., Togashi, K., Fujibayashi, Y., Konishi, J., & Brechbiel, M. W. (2001) · PubMed · Cited by 109
Advances in mRNA non-viral delivery approaches
Ibba, M. L., Ciccone, G., Esposito, C. L., Catuogno, S., & Giangrande, P. H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113930 · Cited by 107
RNAi-based therapeutic strategies for metabolic disease
Czech, M., Aouadi, M., & Tesz, G. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.57 · Cited by 108
Light activated liposomes: Functionality and prospects in ocular drug delivery
Lajunen, T., Nurmi, R., Kontturi, L.-S., Viitala, L., Yliperttula, M. L., Murtomäki, L. S., & Urtti, A. O. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.024 · Cited by 107
Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier
Park, I., Ihm, J., Park, Y., Choi, Y.-J., Kim, S. I., Kim, W. J., Akaike, T., & Cho, C. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00365-6 · Cited by 106
Membrane fusion plays an important role in gene transfection mediated by cationic liposomes
Noguchi, A., Furuno, T., Kawaura, C., & Nakanishi, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00837-0 · Cited by 106
Cationic liposome/DNA complexes: from structure to interactions with cellular membranes
Caracciolo, G., & Amenitsch, H. W. (2012) · European Biophysics Journal · doi:10.1007/s00249-012-0830-8 · Cited by 109
The Potential Role of Proteoglycans in Cationic Lipid-mediated Gene Delivery
Wiethoff, C. M., Smith, J. G., Koe, G. S., & Middaugh, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007940200 · Cited by 105
Sensible use of antisense: how to use oligonucleotides as research tools
Myers, K. J., & Dean, N. M. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01420-0 · Cited by 105
Chen, Z., Tian, Y., Yang, J., Wu, F., Liu, S., Cao, W., Xu, W., Hu, T., Siegwart, D. J., & Xiong, H. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09143 · Cited by 108
Tarahovsky, Y. S., Koynova, R. D., & MacDonald, R. C. (2004) · Biophysical Journal · doi:10.1529/biophysj.104.042895 · Cited by 104
PAMAM Dendrimers as Delivery Agents for Antisense Oligonucleotides
Yoo, H., Sazani, P., & Juliano, R. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018926605871 · Cited by 104
Delivery systems for antisense oligonucleotides
GARCIA-CHAUMONT, C., Seksek, O., Grzybowska, J., Borowski, E., & Bolard, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00062-0 · Cited by 103
Glassman, P. M., Hood, E. D., Ferguson, L. T., Zhao, Z., Siegel, D. L., Mitragotri, S., Brenner, J. S., & Muzykantov, V. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113992 · Cited by 102
Lipid fusion in oligonucleotide and gene delivery with cationic lipids
Mönkkönen, J., & Urtti, A. O. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00004-0 · Cited by 101
Effective intracellular delivery of oligonucleotides in order to make sense of antisense
Shi, F., & Hoekstra, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.016 · Cited by 101
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
Farbiak, L., Cheng, Q., Wei, T., Álvarez‐Benedicto, E., Johnson, L. T., Lee, S. M., & Siegwart, D. J. (2021) · Advanced Materials · doi:10.1002/adma.202006619 · Cited by 103
Hydrophobic Moiety of Cationic Lipids Strongly Modulates Their Transfection Activity
Koynova, R. D., Tenchov, B. G., Wang, L., & MacDonald, R. C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002573 · Cited by 99
Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery
Malamas, A. S., Gujrati, M. D., Kummitha, C. M., Xu, R., & Lu, Z. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.019 · Cited by 97
Engineering Synthetic Vectors for Improved DNA Delivery: Insights from Intracellular Pathways
Roth, C. M., & Sundaram, S. (2004) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.6.040803.140203 · Cited by 99
Lysosome membrane permeability: implications for drug delivery
Lloyd, J. B. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00065-4 · Cited by 96
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA
Toub, N., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.093 · Cited by 96
Kawaura, C., Noguchi, A., Furuno, T., & Nakanishi, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01532-9 · Cited by 96
Zhang, J., Fan, H., Levorse, D. A., & Crocker, L. S. (2011) · Langmuir · doi:10.1021/la104590k · Cited by 96
The role of polymers in enabling RNAi-based technology for sustainable pest management
Quilez‐Molina, A. I., Sánchez, J. N., & Merino, D. (2024) · Nature Communications · doi:10.1038/s41467-024-53468-y · Cited by 96
Nucleic acid delivery: Where material sciences and bio-sciences meet
Remaut, K., Sanders, N. N., Geest, B. G. D., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2007) · Materials Science and Engineering R Reports · doi:10.1016/j.mser.2007.06.001 · Cited by 95
Liang, X., Shen, W., Sun, H., Prakash, T. P., & Crooke, S. T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku484 · Cited by 94
Itaka, K., Harada, A., Nakamura, K., Kawaguchi, H., & Kataoka, K. (2002) · Biomacromolecules · doi:10.1021/bm025527d · Cited by 93
Dias, N., & Stein, C. A. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00060-7 · Cited by 92
Lipid-based systems for the intracellular delivery of genetic drugs
Maurer, N., Mori, A., Palmer, L., Monck, M. A., Mok, K. W. C., Mui, B. L., Akhong, Q.-F., & Cullis, P. R. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294869 · Cited by 91
pH‐Responsive Polymers as Gene Carriers
Park, I., Singha, K., Arote, R. B., Choi, Y., Kim, W. J., & Cho, C. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.200900867 · Cited by 91
Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells
Li, P., Li, D., Zhang, L., Li, G., & Wang, E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.020 · Cited by 90
Light‐Regulated Release of DNA and Its Delivery to Nuclei by Means of Photolabile Gold Nanoparticles
Han, G., You, C., Kim, B., Turingan, R. S., Forbes, N. S., Martin, C. T., & Rotello, V. M. (2006) · Angewandte Chemie · doi:10.1002/ange.200600214 · Cited by 90
Influence of the Membrane Lipid Structure on Signal Processing via G Protein-Coupled Receptors
Yang, Q., Alemany, R., Casas, J., Kitajka, K., Lanier, S. M., & Escribá, P. V. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011692 · Cited by 90
Resina, S., Prévôt, P., & Thierry, A. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006058 · Cited by 88
Polymer- and lipid-based gene delivery technology for CAR T cell therapy
Pinto, I. S., Cordeiro, R. A., & Faneca, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.038 · Cited by 89
Polymeric Nucleic Acid Vehicles Exploit Active Interorganelle Trafficking Mechanisms
Fichter, K. M., Ingle, N. P., McLendon, P. M., & Reineke, T. M. (2012) · ACS Nano · doi:10.1021/nn304218q · Cited by 86
Targeting c-Myb expression in human disease
Ramsay, R. G., Barton, A. L., & Gonda, T. J. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.235 · Cited by 88
Mason, A. J., Martinez, A., Glaubitz, C., Danos, O., Kichler, A., & Bechinger, B. (2005) · The FASEB Journal · doi:10.1096/fj.05-4293fje · Cited by 87
Innovations in Oligonucleotide Drug Delivery
Lysik, M. A., & Wu‐Pong, S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10399 · Cited by 87
Characterization of Lipid DNA Interactions. I. Destabilization of Bound Lipids and DNA Dissociation
Harvie, P., Wong, F. M. P., & Bally, M. B. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77593-9 · Cited by 86
Histonefection: Novel and potent non-viral gene delivery
Kaouass, M., Beaulieu, R., & Balicki, D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.013 · Cited by 84
Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
Mollé, L. M., Smyth, C. H., Yuen, D., & Johnston, A. P. R. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1809 · Cited by 95
Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes
Hinrichs, W. L. J., Sanders, N. N., Smedt, S. C. D., Demeester, J., & Frijlink, H. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.011 · Cited by 84
Uyechi, L. S., Gagné, L., Thurston, G., & Szoka, F. C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301461 · Cited by 84
Self-citationGall, T. L., Loizeau, D., Picquet, E., Carmoy, N., Yaouanc, J., Deschamps, L., Delépine, P., Giamarchi, P., Jaffrès, P., Lehn, P., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900897a · Cited by 88
Rigid nanoparticle-based delivery of anti-cancer siRNA: Challenges and opportunities
Wang, Z., Liu, G., Zheng, H., & Chen, X. S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.020 · Cited by 83
The role of dextran conjugation in transfection mediated by dextran‐grafted polyethylenimine
Tseng, W., Tang, C., & Fang, T. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.572 · Cited by 81
Synthetic Approaches for Nucleic Acid Delivery: Choosing the Right Carriers
Ni, R., Feng, R., & Chau, Y. (2019) · Life · doi:10.3390/life9030059 · Cited by 84
Mahato, R. I., Cheng, K., & Guntaka, R. V. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.3 · Cited by 78
Modifying the host range properties of retroviral vectors
Russell, S. J., & Cosset, F. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199909/10)1:5 · Cited by 84
Developing Small Activating RNA As a Therapeutic: Current Challenges and Promises
Kwok, A., Raulf, N., & Habib, N. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0061 · Cited by 80
Ki-67 as a Molecular Target for Therapy in an In vitro Three-Dimensional Model for Ovarian Cancer
Rahmanzadeh, R., Rai, P., Celli, J. P., Rizvi, I., Baron‐Lühr, B., Gerdes, J., & Hasan, T. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1190 · Cited by 78
Vehicles for oligonucleotide delivery to tumours
Dass, C. R. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021771887 · Cited by 78
Hasegawa, S., Hirashima, N., & Nakanishi, M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301573 · Cited by 78
Recent developments in the hammerhead ribozyme field
Vaish, N. K., Kore, A. R., & Eckstein, F. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.23.5237 · Cited by 78
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Titze-de-Almeida, S. S., Soto‐Sánchez, C., Fernández, E., Koprich, J. B., Brotchie, J. M., & Titze‐de‐Almeida, R. (2020) · Cells · doi:10.3390/cells9040841 · Cited by 81
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments
Stein, C. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00143-8 · Cited by 76
Fischer, W., Calderón, M., Schulz, A., Andreou, I., Weber, M., & Haag, R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900459n · Cited by 75
Bioreducible Liposomes for Gene Delivery: From the Formulation to the Mechanism of Action
Candiani, G., Pezzoli, D., Ciani, L., Chiesa, R., & Ristori, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013430 · Cited by 77
Cationic phospholipids: structure–transfection activity relationships
Koynova, R. D., & Tenchov, B. G. (2009) · Soft Matter · doi:10.1039/b902027f · Cited by 74
Poly( l ‐lysine)‐modified silica nanoparticles for the delivery of antisense oligonucleotides
Zhu, S., Xiang, J., Li, X., Shen, S., Lü, H., Zhou, J. J., Xiong, W., Zhang, B., Nie, X., Zhou, M., et al. (2004) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20030077 · Cited by 74
On the Gene Delivery Efficacies of pH-Sensitive Cationic Lipids via Endosomal Protonation
Singh, R. S., Gonçalves, C., Sandrin, P., Pichon, C., Midoux, P., & Chaudhuri, A. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.026 · Cited by 74
DNA and surfactants in bulk and at interfaces
Dias, R. S., Pais, A. A. C. C., Miguel, M. G., & Lindman, B. (2004) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2004.07.026 · Cited by 74
Zeng, M., Zhou, D., Alshehri, F., Lara‐Sáez, I., Lyu, Y., Creagh-Flynn, J., Xu, Q., Sigen, A., Zhang, J., & Wang, W. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b04098 · Cited by 72
Banerjee, R., Mahidhar, Y. V., Chaudhuri, A., Gopal, V., & Rao, N. M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000466s · Cited by 73
Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides
Wang, S., Sun, H., Tanowitz, M., Liang, X., & Crooke, S. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw595 · Cited by 72
Pozzi, D., Marchini, C., Cardarelli, F., Salomone, F., Coppola, S., Montani, M., Elexpuru-Zabaleta, M., Digman, M. A., Gratton, E., Colapicchioni, V., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.11.014 · Cited by 72
Hybrid vector designs to control the delivery, fate and expression of transgenes
Lam, P. Y. P., & Breakefield, X. O. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200011/12)2:6 · Cited by 29
Keller, M., Harbottle, R. P., Pérouzel, É., Colin, M., Shah, I., Rahim, A. A., Vaysse, L., Bergau, A., Moritz, S., Brahimi‐Horn, C., et al. (2003) · ChemBioChem · doi:10.1002/cbic.200390049 · Cited by 69
Nonviral delivery of genetic medicine for therapeutic angiogenesis
Park, H., Yang, F., & Cho, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.005 · Cited by 68
Qiu, C., Young, M. B. D., Finn, A. V., & Dichek, D. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.4-507 · Cited by 68
Koynova, R. D., & Tenchov, B. G. (2010) · Topics in current chemistry · doi:10.1007/128_2010_67 · Cited by 66
Dynamics of magnetic lipoplexes studied by single particle tracking in living cells
Sauer, A., de Bruin, K. G., Ruthardt, N., Mykhaylyk, O. M., Plank, C., & Bräuchle, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.003 · Cited by 66
Jääskeläinen, I., Peltola, S., Honkakoski, P., Mönkkönen, J., & Urtti, A. O. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00068-3 · Cited by 65
Kowalski, P. S., Lintermans, L. L., Morselt, H. W. M., Leus, N. G. J., Ruiters, M. H. J., Molema, G., & Kamps, J. A. A. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001124 · Cited by 65
Pichon, C. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.504 · Cited by 65
Das, J., Han, J. W., Choi, Y., Song, H., Cho, S., Park, C., Seo, H. G., & Kim, J. (2016) · Scientific Reports · doi:10.1038/srep29197 · Cited by 65
Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides
Benimetskaya, L., Takle, G. Β., Vilenchik, M., Lebedeva, I., Miller, P., & Stein, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.23.5310 · Cited by 65
da Cruz, M. T. G., Simões, S., Pires, P., Nir, S., & de Lima, M. C. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00342-4 · Cited by 64
Dheur, S., Dias, N., Aerschot, A. A. V., Herdewijn, P. A., Bettinger, T., Rémy, J.-S., Hélène, C., & Saison-Behmoaras, E. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.515 · Cited by 64
Moore, N. M., Sheppard, C. L., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1234 · Cited by 63
Khatri, N., Baradia, D., Vhora, I., Rathi, M. N., & Misra, A. R. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0193-9 · Cited by 63
Deshpande, M. C., Garnett, M. C., Vamvakaki, M., Bailey, L., Armes, S. P., & Stolnik, S. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00052-4 · Cited by 63
Gene delivery using temperature-responsive polymeric carriers.
Yokoyama, M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02216-x · Cited by 58
Optimising histidine rich peptides for efficient DNA delivery in the presence of serum
Mason, A. J., Leborgne, C., Moulay, G., Martinez, A., Danos, O., Bechinger, B., & Kichler, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.004 · Cited by 67
Metadata
- Authors
- Zelphati, O., & Szoka, F. C.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1996-10-15
- Volume
- 93
- Issue
- 21
- Pages
- 11493-11498
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC38085
- OpenAlex
- W2018116983
- Cited by
- 634
- References
- 22
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 14 · 2023: 9 · 2022: 9 · 2021: 16 · 2020: 15 · 2019: 26 · 2018: 19 · 2017: 17 · 2016: 21 · 2015: 14 · 2014: 20 · 2013: 24 · 2012: 27
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk046052-07, 5r01gm030163-11)
- National Institute of General Medical Sciences (GM30163)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-46052)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- cationic liposomes, anionic liposomes, phosphatidylserine, lipid flip-flop, endocytosis, nuclear delivery, charge ratio, ion pairing, lipid lateral diffusion, dextran sulfate, heparin, nucleic acid delivery
- MeSH terms
- Base Sequence, Cell Membrane, DNA, Endocytosis, Energy Transfer, Hydrogen-Ion Concentration, Liposomes, Models, Biological, Oligodeoxyribonucleotides, Osmolar Concentration, RNA, Transfer, Serum Albumin, Bovine, Spectrometry, Fluorescence, Spermidine, Spermine, Structure-Activity Relationship, Thionucleotides, Microscopy, Confocal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review